tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

SRZN Stock Latest News

Surrozen Provides Second Quarter 2024 Financial Results and Business Update
Press ReleasesSurrozen Provides Second Quarter 2024 Financial Results and Business Update
1M ago
SRZN
Surrozen Announces Tim Kutzkey’s Board Resignation
PremiumCompany Announcements
Surrozen Announces Tim Kutzkey’s Board Resignation
3M ago
8K
SRZN
Surrozen publishes study in ‘eLife’ on the proprietary SWEETS platform
PremiumThe Fly
Surrozen publishes study in ‘eLife’ on the proprietary SWEETS platform
3M ago
SRZN
Surrozen Publishes Study in ‘eLife’ Demonstrating the Promise of The Proprietary SWEETS Platform, a Unique Targeted Protein Degradation Technology, to Further Enhance Wnt Signaling
PremiumPress Releases
Surrozen Publishes Study in ‘eLife’ Demonstrating the Promise of The Proprietary SWEETS Platform, a Unique Targeted Protein Degradation Technology, to Further Enhance Wnt Signaling
3M ago
SRZN
Surrozen Presents Preliminary Results from Phase 1a Study of SZN-043 in Healthy Volunteers and Patients with a History of Liver Cirrhosis at the 2024 European Association for the Study of the Liver (EASL) in Milan
PremiumPress Releases
Surrozen Presents Preliminary Results from Phase 1a Study of SZN-043 in Healthy Volunteers and Patients with a History of Liver Cirrhosis at the 2024 European Association for the Study of the Liver (EASL) in Milan
3M ago
SRZN
Surrozen presents preliminary results from Phase 1a study of SZN-043
PremiumThe FlySurrozen presents preliminary results from Phase 1a study of SZN-043
3M ago
SRZN
Surrozen initiates dosing of first patient in Phase 1b trial of SZN-043
Premium
The Fly
Surrozen initiates dosing of first patient in Phase 1b trial of SZN-043
4M ago
SRZN
Surrozen Initiates Dosing of First Patient in Phase 1b Clinical Trial of SZN-043 for Severe Alcohol-Associated Hepatitis
Premium
Press Releases
Surrozen Initiates Dosing of First Patient in Phase 1b Clinical Trial of SZN-043 for Severe Alcohol-Associated Hepatitis
4M ago
SRZN
Surrozen presents data demonstrating potentialfor Wnt mimetic technologies
PremiumThe Fly
Surrozen presents data demonstrating potentialfor Wnt mimetic technologies
4M ago
SRZN
Surrozen Presents Data Demonstrating the Promise of Antibody-Based Wnt Mimetics in Treating Cornea Endothelial Dystrophies and Dry Eye Disease at the Associations for Research in Vision and Ophthalmology (ARVO) Annual Meeting
PremiumPress Releases
Surrozen Presents Data Demonstrating the Promise of Antibody-Based Wnt Mimetics in Treating Cornea Endothelial Dystrophies and Dry Eye Disease at the Associations for Research in Vision and Ophthalmology (ARVO) Annual Meeting
4M ago
SRZN
Surrozen Provides First Quarter 2024 Financial Results and Business Update
PremiumPress Releases
Surrozen Provides First Quarter 2024 Financial Results and Business Update
4M ago
SRZN
Surrozen files to sell 1.09M shares of common stock for holders
PremiumThe Fly
Surrozen files to sell 1.09M shares of common stock for holders
5M ago
SRZN
Patent Battles: Surrozen, Inc. at Risk of Financial Instability Amid IP Challenges
PremiumCompany AnnouncementsPatent Battles: Surrozen, Inc. at Risk of Financial Instability Amid IP Challenges
5M ago
SRZN
Surrozen Inc trading resumes
Premium
The Fly
Surrozen Inc trading resumes
5M ago
SRZN
Surrozen Inc trading halted, volatility trading pause
Premium
The Fly
Surrozen Inc trading halted, volatility trading pause
5M ago
SRZN
Surrozen publishes study in ‘Respiratory Research’ on Wnt mimetic tech potential
PremiumThe Fly
Surrozen publishes study in ‘Respiratory Research’ on Wnt mimetic tech potential
6M ago
SRZN
Surrozen Publishes Study in ‘Respiratory Research’ Demonstrating the Promise of a Wnt Mimetic Antibody in Treating Pulmonary Fibrosis
PremiumPress Releases
Surrozen Publishes Study in ‘Respiratory Research’ Demonstrating the Promise of a Wnt Mimetic Antibody in Treating Pulmonary Fibrosis
6M ago
SRZN
Surrozen Highlights SZN-043 Data on Safety and Liver Function
PremiumCompany Announcements
Surrozen Highlights SZN-043 Data on Safety and Liver Function
6M ago
8K
SRZN
Surrozen announces up to $192.5M private placement
PremiumThe Fly
Surrozen announces up to $192.5M private placement
6M ago
SRZN
Surrozen Announces up to $192.5 Million Private Placement of Securities Priced At-the-Market Under Nasdaq Rules
PremiumPress ReleasesSurrozen Announces up to $192.5 Million Private Placement of Securities Priced At-the-Market Under Nasdaq Rules
6M ago
SRZN
Surrozen Announces Safety, Pharmacodynamic and Liver Function Data for SZN-043
Premium
Press Releases
Surrozen Announces Safety, Pharmacodynamic and Liver Function Data for SZN-043
6M ago
SRZN
Surrozen announces safety, pharmacodynamic, liver function data for SZN-043
Premium
The Fly
Surrozen announces safety, pharmacodynamic, liver function data for SZN-043
6M ago
SRZN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >